All Infection Prevention & Control articles – Page 7
-
NewsRisk for Lyme disease in Ohio is equal to Connecticut, study shows
The risk for being bitten by a tick infected with bacteria that cause Lyme disease is as high in Ohio as it is for those living in Northeast states that have dealt with Lyme disease for over 50 years, according to a new study.
-
NewsWhy aren’t more older adults getting flu or COVID-19 shots?
This winter’s brutal flu season isn’t over, and COVID-19 cases have risen recently too. But a new poll taken in recent weeks shows that vaccination against both viruses lags among people 50 and over, and the US survey reveals key reasons why.
-
NewsWHO calls for mental health to be central to neglected tropical disease care
A major new World Health Organization publication sets out, for the first time, a practical, evidence-based package of care to address the mental health impacts of neglected tropical diseases (NTDs) and the stigma that can prevent people from seeking care and participating fully in society.
-
NewsCommon bacteria discovered in the eye linked to cognitive decline
Chlamydia pneumoniae can linger in the eye and brain for years and may aggravate Alzheimer’s disease. Research suggests this bacterium can amplify Alzheimer’s disease and points to potential interventions including inflammation-limiting therapies and early antibiotic treatment.
-
NewsNew dashboard helps predict and plan for disease outbreaks
When infectious diseases surge, response often comes down to whether communities can position the right people and supplies before case counts spike. Researchers have designed a new platform to translate academic disease forecasting into actionable guidance for decision-makers.
-
NewsSynthetic compound has the potential to treat malaria and prevent its transmission
Tests on cell cultures and rodents have shown that the new molecule acts on all three stages of the disease cycle, eliminating the parasite from human blood and liver and preventing transmission to mosquitoes.
-
NewsSix years after COVID-19’s global alarm: Is the world better prepared for the next pandemic?
Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease. As we cross this six-year mark, WHO asks: Is the world better prepared for the next pandemic?
-
NewsStudy suggests far fewer cervical cancer screenings are needed for HPV‑vaccinated women
In a modeling study of women vaccinated against human papillomavirus (HPV), researchers found that cervical cancer screening could be done far less often than current recommendations without compromising health benefits.
-
NewsDanish pediatrician warns Denmark’s childhood vaccine schedule is not one the U.S. can copy
Danish pediatrician Lone Graff Stensballe DMSc, PhD warns that the U.S. should not replicate Denmark’s childhood vaccine strategy due to major social and health disparities between the two countries.
-
NewsDissolved bubble microneedles enable more efficient therapy of acne vulgaris
Researchers report a new microneedle-based strategy for acne therapy in a new study. The team developed dissolved bubble microneedle patches that can simultaneously deliver hydrophilic and hydrophobic drugs directly into acne-affected skin.
-
NewsNipah virus outbreak: Risk of global threat is low, say experts
The Global Virus Network is monitoring reports of a Nipah virus outbreak in India and emphasizes that such cases, while very concerning and serious, are not unexpected or unprecedented.
-
NewsFrom biocidal coatings to medicines: A nanocomposite sting for microorganisms
A surface capable of responding to chemical signals generated by microorganisms and automatically producing biocidal substances – a description of how the B-STING silica nanocomposite works. The new material acts as a nanofactory of reactive oxygen species, activating only when necessary.
-
NewsAddressing rapid viral evolution: research team unveils emerging techniques for RNA viruses diagnostics
The rapid evolutionary dynamics of RNA viruses, driven by high mutation rates and the consequent formation of complex quasispecies populations, present a formidable obstacle to conventional molecular diagnostic approaches, warn researchers.
-
NewsNasal vaccine combats bird flu infection in rodents
Researchers have developed an intranasal H5N1 vaccine that elicited strong immune responses when tested in hamsters and mice and prevented infections in exposed animals. The team also confirmed their vaccine remained effective regardless of prior flu exposure.
-
NewsA rapid test using a mobile phone will be able to identify the most severe cases of imported malaria within minutes
A new malaria tool uses a mobile phone to combine rapid diagnostic tests with video analysis and is capable not only of detecting the infection in under six minutes but also of predicting which patients may develop severe forms of malaria.
-
NewsInstitut Pasteur issues statement on U.S. administration’s attacks against biomedical research, global public health action and vaccination
For several months now, the current U.S. administration has consistently attacked and endeavored to weaken biomedical research and public health action in the United States and worldwide with unparalleled vigor, the Institut Pasteur has said in a new statement.
-
NewsNew tool shows how to enter and change pneumocystis fungi
Researchers have reported success in genetically modifying the fungal pathogen Pneumocystis murina. Their approach uses extracellular vesicles from mouse lungs to deliver gene-modifying molecules inside the fungal cells. The modified fungus expressed the introduced genomic modifications.
-
NewsIn rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to one kind of Chikungunya vaccine, which is no longer available in the U.S.
-
NewsNew platform could develop vaccines faster than ever before
Scientists are optimizing a vaccine-development platform created to accelerate how quickly life-saving vaccines can be designed and deployed during infectious-disease outbreaks such as the COVID-19 pandemic.
-
NewsPreparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at least two years after a booster vaccination.